0001972362-23-000114.txt : 20230510 0001972362-23-000114.hdr.sgml : 20230510 20230510190726 ACCESSION NUMBER: 0001972362-23-000114 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230510 DATE AS OF CHANGE: 20230510 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 23908263 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Sabba Stephen L CENTRAL INDEX KEY: 0001442372 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: DORSET MANAGEMENT CORP STREET 2: 485 UNDERHILL BLVD SUITE 205 CITY: SYOSSET STATE: NY ZIP: 11791 144 1 primary_doc.xml 144 0001442372 XXXXXXXX LIVE 0000886163 LIGAND PHARMACEUTICALS INC 001-33093 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500 Sabba Stephen L Officer COMMON ETRADE FINANCIAL CORPORATION

3 EDISON DRIVE ALPHARETTA GA 30005

6408 494224.97 16900000 05/10/2023 NASDAQ COMMON 05/10/2023 STOCK OPTION EXERCISE ISSUER N 6408 05/10/2023 COMPENSATION Y 05/10/2023 /s/ Stephen L Sabba